We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

XIFR:NYSEXPLR Infrastructure, LP Analysis

Data as of 2026-07-20 - not real-time

$12.02

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

XPLR Infrastructure, LP trades at $12.02, hovering just below its 20‑day SMA (12.08) but above the 50‑day (11.87) and 200‑day (10.50) averages, suggesting a marginally bullish bias despite a bearish MACD histogram. The stock’s PE of 9.85 is well under the industry average of 20.85, yet the DCF‑derived fair value of $5.10 implies the market price is more than double intrinsic estimates, flagging potential overvaluation. Financial health is a concern: the company carries $6.33 B of debt against $943 M of cash, yielding a debt‑to‑equity ratio near 59 and negative free cash flow of $‑241 M, while operating margins are negative at –6.2 % and ROE is –1.2 %. On the technical side, volatility is elevated at 26.8 % over 30 days and beta exceeds 1, indicating sensitivity to market swings, which aligns with the “Extreme Greed” sentiment from the Fear & Greed Index.
The upcoming Q2 2026 earnings release (July 28) could act as a catalyst, but given the mixed technical signals, high leverage, and the stark gap between market price and DCF valuation, investors should approach XIFR cautiously, weighing short‑term price dynamics against long‑term financial sustainability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support at $11.38 with limited upside to $12.77 resistance
  • Bearish MACD histogram and neutral RSI suggest limited near‑term upside
  • Upcoming Q2 earnings could increase volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • High debt‑to‑equity ratio (~59) and negative free cash flow
  • Forward EPS collapse to $0.09 and forward PE of 133x
  • Valuation gap between market price and DCF fair value

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • DCF fair value (~$5.10) indicates the stock is significantly overvalued
  • Sustained leverage and weak profitability raise solvency concerns
  • Extreme market greed may mask underlying financial weakness

Key Metrics & Analysis

Financial Health

Revenue Growth-2.50%
Profit Margin8.72%
P/E Ratio9.9
ROE-1.20%
ROA0.06%
Debt/Equity58.96
P/B Ratio0.4
Op. Cash Flow$644.0M
Free Cash Flow$-241375008
Industry P/E20.9

Technical Analysis

TrendBullish
RSI49.7
Support$11.38
Resistance$12.77
MA 20$12.08
MA 50$11.87
MA 200$10.49
MACDBearish
VolumeStable
Fear & Greed Index87.91

Valuation

Fair Value$5.10
Target Price$12.14
Upside/Downside0.97%
GradeOvervalued
TypeValue

Risk Assessment

Beta1.11
Volatility26.75%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.